focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Director Dealing

22 Dec 2015 15:08

RNS Number : 9133J
FastForward Innovations Limited
22 December 2015
 

For immediate release

22 December 2015

FastForward Innovations Limited

("FastForward" or the "Company")

Placing

Director Dealing

Further to the announcement by FastForward Innovations Limited (AIM: FFWD) on 21 December 2015, the Company is pleased to announce that it has today agreed to place 39,668,200 new Ordinary Shares of 1p each (the "Placing Shares") at a price of 8p per Placing Share with a number of new investors thereby raising US$4,830,000 (£3,173,456 at an exchange rate of £1:US$1.522, being the rate on the date the Company determined the terms of the placing) before expenses (the "Placing"). The proceeds of the Placing will be used to assist the Company in making investments in accordance with its investing policy and for general working capital purposes.

In accordance with the terms of subscription letters signed by investors, payment for the Placing Shares is due by 5 January 2016. Subject to payment, the Placing Shares (which will rank pari passu with the existing Ordinary Shares) will be issued and allotted on 8 January 2016, with application for the Placing Shares to be admitted to trading on AIM ("Admission") and dealings commencing at 8.00 a.m. on 11 January 2016. The Company expects that the enlarged issued share capital following the issue of the Placing Shares and also the consideration shares to be issued on completion of the Vemo acquisition (as announced on 21 December 2015) will be 96,681,544 Ordinary Shares (the "Enlarged Issued Share Capital").

Related Party Transaction

Mr Stephen Dattels, Mr Jim Mellon and Mr Ian Burns (who are each Directors of the Company) have each participated in the Placing. In addition, the Company announced on 21 December 2015 that, subject to regulatory approvals being received, it was proposed Mr Lorne Abony be appointed as a director of the Company. The participation of the Directors, and the proposed director Mr Abony, is as set out below:

Name

Subscription

Placing Shares

Total Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital

Stephen Dattels1

US$590,000

4,845,598

12,870,067

13.31%

Jim Mellon2

US$150,000

1,231,932

9,256,401

9.57%

Ian Burns3

US$15,000

123,193

1,374,024

1.42%

Lorne Abony

US$2,000,000

16,425,756

20,754,181

21.47%

1 Mr Dattels' interest in shares is held by Regent Mercantile Holdings Limited, a company owned by a trust under which Mr Dattels is a discretionary beneficiary.

2 Mr Mellon's interest in shares is held by Galloway Limited, a company owned by a trust of which Mr James Mellon is a life tenant.

3 Mr Burns' interest in shares is held by Smoke Rise Holdings Limited, a company of which he is the sole shareholder.

The Directors are related parties for the purposes of the AIM Rules and it has also been deemed that Mr Abony, should also be treated as a related party for the purposes of the AIM Rules given his proposed appointment to the Board. The participation of the three Directors and Mr Abony in the Placing constitutes a Related Party Transaction under Rule 13 of the AIM Rules for Companies.

Accordingly, Mr Bryan Smith, the independent director of the Company, confirms that, having consulted with the Company's Nominated Adviser, the terms of the Placing are fair and reasonable insofar as the Company's shareholders are concerned. In particular Mr Smith notes that the Directors and Mr Abony have participated on the same terms as all other investors.

The Investors

In addition to Mr Abony, Mr Mellon and Mr Dattels, following the issue of the Placing Shares the following shareholders will be interested in more than 3 per cent. of the Enlarged Issued Share Capital :

Name

Number of Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital

Mr Norbert Teufelberger

4,106,439

4.25%

Russell Geyser

3,285,151

3.40%

Wendy Polland

3,285,151

3.40%

Issued Shares

Following Admission of the Placing Shares and the consideration shares to be issued on completion of the Vemo acquisition (as announced on 21 December 2015), the Company's enlarged issued share capital will consist of 96,681,544 Ordinary Shares with voting rights. This number may be used by shareholders, following the Placing, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please visit www.kualainnovations.com or contact:

James Biddle/ Michael Cornish (Nomad)

Beaumont Cornish LimitedTel: +44 207 628 3396

 

Peterhouse Corporate Finance Limited

Guy Miller/ Lucy Williams

Tel: +44 (0) 207 469 0930

Elysium Fund Management Limited

PO Box 650

1st Floor

Royal Chambers

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: elysium@elysiumfundman.com

 

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Limited. There can be no assurance that such statements will prove to be accurate, achievable or recognisable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMMZZKZDGKZM
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.